Medicare Enrolled
Dr. Paul Chan, MD
Urology Physician · Arlington, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chan
Dr. Paul Chan is an urology physician in Arlington, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chan performed 2,156 Medicare services across 1,548 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chan received a total of $3,757 from 31 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 46% volume in TX
$3,757 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,156
Medicare services
Top 46% in TX for urology physician
1,548
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~108 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
411 | $88 | $285 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
234 | $6 | $12 |
| PSA test (prostate cancer screening) | 223 | $18 | $41 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
180 | $2 | $5 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
128 | $8 | $24 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
128 | $0 | $1 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
69 | $69 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $116 | $368 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
63 | $10 | $32 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
46 | $171 | $538 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
46 | $34 | $376 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
46 | $34 | $205 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
46 | $34 | $120 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
42 | $175 | $546 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $109 | $316 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $54 | $203 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
25 | $550 | $1,332 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
23 | $3 | $8 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
23 | $27 | $62 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
23 | $25 | $57 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
23 | $34 | $77 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
23 | $34 | $77 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
23 | $34 | $77 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
23 | $34 | $77 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
23 | $34 | $77 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
23 | $34 | $77 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
22 | $2 | $5 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
22 | $2 | $5 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
21 | $74 | $239 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
19 | $8 | $19 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
19 | $6 | $14 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
12 | $442 | $1,689 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,757
Total received (2018-2024)
Avg $537/year across 7 years
Top 45% in TX for urology physician
31
Companies
233
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,757 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$188
2023
$223
2022
$711
2021
$669
2020
$687
2019
$555
2018
$724
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$786
Endo Pharmaceuticals Inc.
$515
PFIZER INC.
$247
Boston Scientific Corporation
$196
UROVANT SCIENCES INC
$187
C. R. Bard, Inc. & Subsidiaries
$186
Blue Earth Diagnostics Limited
$174
Myovant Sciences Inc.
$158
ABBVIE INC.
$155
Axonics, Inc.
$142
Dendreon Pharmaceuticals LLC
$139
Janssen Biotech, Inc.
$107
Olympus America Inc.
$100
AbbVie Inc.
$84
Coloplast Corp
$83
Sumitomo Pharma America, Inc.
$68
NeoTract Inc.
$48
Innovation Technologies Inc
$48
Bayer HealthCare Pharmaceuticals Inc.
$48
Retrophin, Inc.
$37
Clarus Therapeutics Inc.
$35
GENZYME CORPORATION
$34
UroGen Pharma, Inc.
$27
CIVCO Medical Instruments
$25
180 Medical, Inc.
$25
Allergan Inc.
$24
AbbVie, Inc.
$20
Acerus Pharmaceuticals Corporation
$17
Myriad Genetic Laboratories, Inc.
$16
Mission Pharmacal Company
$13
Avadel Specialty Pharmaceuticals, LLC
$13
Top 3 companies account for 41.2% of total payments
Associated products mentioned in payments ›
(815) Thiola · AVEED · Androgel · Axonics · Axumin · BOTOX · Bulkamid · CHANTIX · EDEX · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · IRRISEPT · Inlay · Isiris aStent Removal Device · JATENZO · JELMYTO · JEVTANA · LUPRON DEPOT · LithoVue · MYRBETRIQ · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Cysto-Resection · POSLUMA · PROVENGE · Prolaris · Uribel · UroLift · Varithena Administration Pack · XIAFLEX · XTANDI · Xofigo · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $174 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
144
Per 100K population
6.7
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chan performed 411 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chan receive payments from pharmaceutical companies?
Yes. Dr. Chan received a total of $3,757 from 31 companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chan's costs compare to other urology physicians in Arlington?
Dr. Chan's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Arlington
Browse urology physicians in Arlington ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology